Vault-13

First Turn Management, LLC

DEL MAR, CA · CIK 1993440 · 13F filing filed 2025-02-14

SEC-registered investment adviser since 2023 · limited liability company

As an employer

$558.3m reported value -11.6% vs Q3 2024
36positions
44.8%in top 10
7 new 11 added 13 reduced 9 sold out vs Q3 2024

Holdings, Q4 2024

The small lines show how much was held over the last 4 quarters (adjusted for stock splits).

#SecurityTickerShares Value% of portfolioChangeShares change
1 INSMED INC COM PAR $.01 INSM INSM 446,980 $30.9m5.53% 5.53% AddedShares held: Q1 2024 0, Q2 2024 323.4k, Q3 2024 356.5k, Q4 2024 447.0k +90.5k +90,529 25.4%
2 VERONA PHARMA PLC SPONSORED ADS VRNA VRNA 641,901 $29.8m5.34% 5.34% AddedShares held: Q1 2024 973.1k, Q2 2024 0, Q3 2024 572.9k, Q4 2024 641.9k +69.0k +68,973 12.0%
3 XENON PHARMACEUTICALS INC COM XENE XENE 684,986 $26.9m4.81% 4.81% AddedShares held: Q1 2024 680.4k, Q2 2024 339.9k, Q3 2024 325.2k, Q4 2024 685.0k +359.8k +359,768 110.6%
4 ARGENX SE SPONSORED ADR ARGX ARGX 43,078 $26.5m4.75% 4.75% ReducedShares held: Q1 2024 80.0k, Q2 2024 80.0k, Q3 2024 54.4k, Q4 2024 43.1k -11.4k -11,362 -20.9%
5 INTRA-CELLULAR THERAPIES INC COM ITCI ITCI 294,414 $24.6m4.40% 4.40% AddedShares held: Q1 2024 206.7k, Q2 2024 347.3k, Q3 2024 254.8k, Q4 2024 294.4k +39.6k +39,614 15.6%
6 NUVALENT INC COM COM 309,521 $24.2m4.34% 4.34% ReducedShares held: Q1 2024 265.9k, Q2 2024 252.3k, Q3 2024 359.1k, Q4 2024 309.5k -49.6k -49,593 -13.8%
7 CRINETICS PHARMACEUTICALS IN COM CRNX CRNX 453,376 $23.2m4.15% 4.15% AddedShares held: Q1 2024 0, Q2 2024 369.3k, Q3 2024 353.4k, Q4 2024 453.4k +100.0k +100,000 28.3%
8 VAXCYTE INC COM PCVX PCVX 276,905 $22.7m4.06% 4.06% AddedShares held: Q1 2024 260.3k, Q2 2024 260.3k, Q3 2024 212.0k, Q4 2024 276.9k +64.9k +64,920 30.6%
9 MIRUM PHARMACEUTICALS INC COM MIRM MIRM 506,908 $21.0m3.75% 3.75% ReducedShares held: Q1 2024 958.7k, Q2 2024 703.4k, Q3 2024 647.6k, Q4 2024 506.9k -140.7k -140,703 -21.7%
10 JANUX THERAPEUTICS INC COM JANX JANX 383,602 $20.5m3.68% 3.68% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 383.6k
11 VERA THERAPEUTICS INC CL A VERA VERA 464,807 $19.7m3.52% 3.52% AddedShares held: Q1 2024 118.3k, Q2 2024 212.9k, Q3 2024 326.5k, Q4 2024 464.8k +138.3k +138,313 42.4%
12 INTUITIVE SURGICAL INC COM NEW ISRG ISRG 35,032 $18.3m3.27% 3.27% AddedShares held: Q1 2024 0, Q2 2024 41.9k, Q3 2024 30.3k, Q4 2024 35.0k +4.8k +4,778 15.8%
13 REVOLUTION MEDICINES INC COM RVMD RVMD 403,915 $17.7m3.16% 3.16% NewShares held: Q1 2024 0, Q2 2024 329.5k, Q3 2024 0, Q4 2024 403.9k
14 EXACT SCIENCES CORP COM EXAS EXAS 309,890 $17.4m3.12% 3.12% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 309.9k
15 AXSOME THERAPEUTICS INC COM AXSM AXSM 192,146 $16.3m2.91% 2.91% ReducedShares held: Q1 2024 342.2k, Q2 2024 337.2k, Q3 2024 255.3k, Q4 2024 192.1k -63.1k -63,148 -24.7%
16 NATERA INC COM NTRA NTRA 99,159 $15.7m2.81% 2.81% ReducedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 155.7k, Q4 2024 99.2k -56.5k -56,491 -36.3%
17 GLAUKOS CORP COM GKOS GKOS 96,097 $14.4m2.58% 2.58% UnchangedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 96.1k, Q4 2024 96.1k
18 GERON CORP COM GERN GERN 3,893,327 $13.8m2.47% 2.47% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 3.1m, Q4 2024 3.9m +768.4k +768,360 24.6%
19 BRIDGEBIO PHARMA INC COM BBIO BBIO 452,290 $12.4m2.22% 2.22% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 399.8k, Q4 2024 452.3k +52.5k +52,509 13.1%
20 ASCENDIS PHARMA A/S SPONSORED ADR SPONSORED ADR 87,804 $12.1m2.17% 2.17% ReducedShares held: Q1 2024 151.6k, Q2 2024 186.6k, Q3 2024 150.6k, Q4 2024 87.8k -62.8k -62,789 -41.7%
21 HEALTHEQUITY INC COM HQY HQY 125,867 $12.1m2.16% 2.16% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 125.9k
22 ENLIVEN THERAPEUTICS INC COM ELVN ELVN 535,092 $12.0m2.16% 2.16% UnchangedShares held: Q1 2024 0, Q2 2024 413.2k, Q3 2024 535.1k, Q4 2024 535.1k
23 DAY ONE BIOPHARMACEUTICALS I COM COM 947,878 $12.0m2.15% 2.15% UnchangedShares held: Q1 2024 1.3m, Q2 2024 0, Q3 2024 947.9k, Q4 2024 947.9k
24 MERUS N V COM MRUS MRUS 285,159 $12.0m2.15% 2.15% ReducedShares held: Q1 2024 0, Q2 2024 321.9k, Q3 2024 308.0k, Q4 2024 285.2k -22.9k -22,855 -7.4%
25 ADMA BIOLOGICS INC COM ADMA ADMA 684,230 $11.7m2.10% 2.10% AddedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 665.0k, Q4 2024 684.2k +19.2k +19,245 2.9%
26 ORIC PHARMACEUTICALS INC COM ORIC ORIC 1,451,037 $11.7m2.10% 2.10% UnchangedShares held: Q1 2024 1.1m, Q2 2024 1.5m, Q3 2024 1.5m, Q4 2024 1.5m
27 ARCELLX INC COMMON STOCK ACLX ACLX 152,356 $11.7m2.09% 2.09% ReducedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 214.3k, Q4 2024 152.4k -61.9k -61,942 -28.9%
28 APOGEE THERAPEUTICS INC COM COM 252,725 $11.4m2.05% 2.05% NewShares held: Q1 2024 379.8k, Q2 2024 318.3k, Q3 2024 0, Q4 2024 252.7k
29 HARROW INC COM HROW HROW 304,874 $10.2m1.83% 1.83% ReducedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 326.6k, Q4 2024 304.9k -21.7k -21,708 -6.7%
30 BIOHAVEN LTD COM BHVN BHVN 262,442 $9.8m1.76% 1.76% ReducedShares held: Q1 2024 432.3k, Q2 2024 366.0k, Q3 2024 315.8k, Q4 2024 262.4k -53.4k -53,374 -16.9%
31 CORMEDIX INC COM CRMD CRMD 1,021,421 $8.3m1.48% 1.48% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 1.0m
32 ARS PHARMACEUTICALS INC COM SPRY SPRY 593,291 $6.3m1.12% 1.12% UnchangedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 593.3k, Q4 2024 593.3k
33 BICARA THERAPEUTICS INC COM BCAX BCAX 346,170 $6.0m1.08% 1.08% ReducedShares held: Q1 2024 0, Q2 2024 0, Q3 2024 562.4k, Q4 2024 346.2k -216.2k -216,221 -38.5%
34 BLUEPRINT MEDICINES CORP COM BPMC BPMC 67,143 $5.9m1.05% 1.05% ReducedShares held: Q1 2024 0, Q2 2024 184.9k, Q3 2024 178.9k, Q4 2024 67.1k -111.8k -111,786 -62.5%
35 SYNDAX PHARMACEUTICALS INC COM SNDX SNDX 441,587 $5.8m1.05% 1.05% ReducedShares held: Q1 2024 0, Q2 2024 640.4k, Q3 2024 1.2m, Q4 2024 441.6k -745.6k -745,578 -62.8%
36 PRAXIS PRECISION MEDICINES I COM NEW PRAX PRAX 45,536 $3.5m0.63% 0.63% NewShares held: Q1 2024 0, Q2 2024 0, Q3 2024 0, Q4 2024 45.5k

Sold out since Q3 2024

SecurityTickerShares held beforeValue then
TRANSMEDICS GROUP INC TMDX TMDX 114,247 $17.9m114.2k shares
VERTEX PHARMACEUTICALS INC VRTX VRTX 35,222 $16.4m35.2k shares
ESTABLISHMENT LABS HLDGS INC ESTA ESTA 357,003 $15.4m357.0k shares
REPLIGEN CORP RGEN RGEN 88,714 $13.2m88.7k shares
KRYSTAL BIOTECH INC KRYS KRYS 67,942 $12.4m67.9k shares
CYTOKINETICS INC CYTK CYTK 223,147 $11.8m223.1k shares
ROCKET PHARMACEUTICALS INC RCKT RCKT 621,306 $11.5m621.3k shares
RELAY THERAPEUTICS INC RLAY RLAY 1,226,354 $8.7m1.2m shares
KALVISTA PHARMACEUTICALS INC KALV KALV 355,000 $4.1m355.0k shares